The upswing comes on the heels of a setback that led to Attridge recording a loss of $11.96 million between Oct. 2 …
Aspen Pharmacare
-
-
At the helm of Aspen Pharmacare, Attridge has made significant contributions to Africa’s healthcare sector.
-
Beyond Aspen Pharmacare, Saad’s influence extends to a diverse array of companies, each representing a facet of his entrepreneurial prowess.
-
Apart from his executive and governance roles in Aspen Pharmacare, Attridge owns a notable 4.28-percent stake in Aspen.
-
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding …
-
Apart from his executive and governance roles in Aspen Pharmacare, Saad also holds a controlling 12.5-percent stake in the company.
-
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding …
-
Established in 1997 by Saad, Aspen has steadily expanded its global presence in the pharmaceutical sector.
-
Attridge, Aspen’s group chief advisor, owns a 4.26-percent stake in the pharmaceutical company.
- Southern Africa
South African billionaire Stephen Saad’s Aspen partners with Eli Lilly to expand medical access
Aspen Pharmacare, founded by Saad in 1997, has steadily fortified its global presence in the pharmaceutical sector for over two decades.